{
  "trial_id": "NCT01568359",
  "overall_assessment": "likely_eligible",
  "inclusion": [
    {
      "criterion": "diagnosis",
      "label": "met",
      "evidence": "acromegaly or nonfunctioning pituitary"
    },
    {
      "criterion": "treatment",
      "label": "met",
      "evidence": "pituitary condition treatment"
    },
    {
      "criterion": "consent",
      "label": "met",
      "evidence": "written consent"
    },
    {
      "criterion": "site",
      "label": "met",
      "evidence": "Emory Clinic/Emory University hospital"
    },
    {
      "criterion": "stage of disease",
      "label": "met",
      "evidence": "active acromegaly or nonfunctioning pituitary adenoma"
    },
    {
      "criterion": "age",
      "label": "met",
      "evidence": "> 18 years old"
    }
  ],
  "exclusion": [
    {
      "criterion": "age",
      "label": "not_met",
      "evidence": "< 18 years old"
    },
    {
      "criterion": "prior other diseases",
      "label": "unknown",
      "evidence": "chronic renal disease stage 3 or worse (estimated GFR > 60)"
    }
  ],
  "notes": "41-year-old man with acromegaly, underwent transsphenoidal surgery 4 months ago. Lab studies show IGF-1 level of 4.5 ULN adjusted by sex and age.",
  "_meta": {
    "topic_id": "56",
    "trial_id": "NCT01568359",
    "model": "llama3.1:8b",
    "run_tag": "llama31_8b_full_top100",
    "top_k": 100
  }
}